Suppression of TNF-α Expression, Inhibition of Th1 Activity, and Amelioration of Collagen-Induced Arthritis by Rolipram

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6253-6259

  Ross, Susan E ^a   Williams, Richard O ^a   Mason, Lesley J ^a   Mauri, Claudia ^a   Marinova Mutafchieva, Lilia ^a   Malfait, Anne Marie ^a   Maini, Ravinder N ^a   Feldmann, Marc ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRROLIDONE DERIVATIVE; CD4 ANTIGEN; COLLAGEN; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTHRITIS; ARTICLE; BIOSYNTHESIS; CATTLE; DBA MOUSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; IMMUNOLOGY; MALE; METABOLISM; MOUSE; TH1 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTIGENS, CD4; ARTHRITIS; CATTLE; COLLAGEN; CYTOKINES; DOWN-REGULATION; DRUG THERAPY, COMBINATION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-12; MALE; MICE; MICE, INBRED DBA; PYRROLIDINONES; ROLIPRAM; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031573618     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Brennan, F. M., D. Chantry, A. Jackson, R. Maini, and M. Feldmann. 1989. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2:244.
2. Chu, C. Q., M. Field, M. Feldmann, and R. N. Maini. 1991. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 34:1125.
3. Haworth, C., F. M. Brennan, D. Chantry, M. Turner, R. N. Maini, and M. Feldmann. 1991. Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α. Eur. J. Immunol. 21:2575.
4. Dayer, J. M., B. Beutler, and A. Cerami. 1985. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163.
5. Gamble, J. R., J. M. Harlan, S. J. Klebanoff, and M. A. Vadas. 1985. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. USA 82:8667.
6. Cavender, D., Y. Saegusa, and M. Ziff. 1987. Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J. Immunol. 139:1855.
7. Thorbecke, G. J., R. Shah, C. H. Leu, A. P. Kuruvilla, A. M. Hardison, and M. A. Palladino. 1992. Involvement of endogenous tumor necrosis factor α and transforming growth factor β during induction of collagen type II arthritis in mice. Proc. Natl. Acad. Sci. USA 89:7375.
8. Cooper, W. O., R. A. Fava, C. A. Gates, M. A. Cremer, and A. S. Townes. 1992. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin. Exp. Immunol. 89-244.
9. Brahn, E., D. J. Peacock, M. L. Banquerigo, and D. Y. Liu. 1992. Effects of tumor necrosis factor alpha (TNF-α) on collagen arthritis. Lymphokine Cytokine Res. 11:253.
10. Williams, R. O., M. Feldmann, and R. N. Maini. 1992. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 89:9784.
11. Piguet, P. F., G. E. Grau, C. Vesin, H. Loetscher, R. Gentz, and W. Lesslauer. 1992. Evolution of collagen arthritis in mice is arrested by treatment with antitumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510.
12. Elliott, M. J., R. N. Maini, M. Feldmann, A. Long-Fox, P. Charles, P. Katsikis, F. M. Brennan, J. Walker, H. Bijl, J. Ghrayeb, and J. N. Woody. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumour necrosis factor α. Arthritis Rheum. 36:1681.
13. Waldmann, T. A. 1991. Monoclonal antibodies in diagnosis and therapy. Science 252:1657.
14. Wachtel, H. 1982. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology 77:309.
15. Wachtel, H. 1990. The second-messenger dysbalance hypothesis of affective disorders. Pharmacopsychiatry 23:27.
16. Wachtel, H. 1983. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitor rolipram in rats in vivo. J. Pharm. Pharmacol. 35:440.
17. Krause, W., G. Kuhne, and H. Matthes. 1989. Pharmacokinetics of the antidepressant rolipram in healthy volunteers. Xenobiotica 19:683.
18. Nicholson, C. D., R. A. Challiss, and M. Shahid. 1991. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. Sci. 12:19.
19. Sekut, L., D. Yarnall, S. A. Stimpson, L. S. Noel, R. Bateman-Fite, R. L. Clark, J. A. Menius, Jr., and K. M. Connolly. 1995. Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clin. Exp. Immunol. 100:126.
20. Semmler, J., H. Wachtel, and S. Endres. 1993. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells. Int. J. Immunopharmacol. 15:409.
21. McLaughlin, M. M., L. B. Cieslinski, M. Burman, T. J. Torphy, and G. P. Livi. 1993. A low-Km, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain: cloning and expression of cDNA. biochemical characterization of recombinant protein, and tissue distribution of mRNA J. Biol. Chem. 268:6470.
22. Turner, N. C., L. J. Wood, F. M. Burns, T. Gueremy, and J. E. Souness. 1993. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages. Br. J. Pharmacol. 108:876.
23. Suttorp, N., U. Weber, T. Welsch, and C. Schudt. 1993. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91:1421.
24. Bulut, V., A. Severn, and F. Y. Liew. 1993. Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem. Biophys. Res. Commun. 195:1134.
25. Torphy, T. J. and B. J. Undem. 1991. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46:512.
26. Sommer, N., P. A. Loschmann, G. H. Northoff, M. Weller, A. Steinbrecher, R. Lichtenfels, R. Meyermann, A. Riethmuller, and A. Fontana. 1995. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med. 1:244.
27. Genain, C. P., T. Roberts, R. L. Davis, M. H. Nguyen, A. Uccelli, D. Faulds, Y. Li, J. Hedgpeth, and S. L. Hauser. 1995. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92:3601.
28. Williams, R. O., L. J. Mason, M. Feldmann, and R. N. Maini. 1994. Synergy between anti-CD4 and anti-TNF in the amelioration of established collagen-induced arthritis. Proc. Natl. Acad. Sci. USA 91:2762.
29. Miller, E. J. 1972. Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin. Biochemistry 11:4903.
30. Galfre, G., C. Milstein, and B. Wright. 1979. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG. Nature 277:131.
31. Cobbold, S. P., A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
32. Qin, S., S. Cobbold, H. Tighe, R. Benjamin, and H. Waldmann. 1987. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur. J. Immunol. 17:1159.
33. Marinova-Mutafchieva, L., R. O. Williams, L. J. Mason, C. Mauri, M. Feldmann, and R. N. Maini. 1997. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107:507.
34. Mauri, C., R. O. Williams, M. Walmsley, and M. Feldmann. 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol 26:1511.
35. Roach, T. I., A. F. Kiderlen, and J. M. Blackwell. 1991. Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect. Immun. 59:3935.
36. Gerlier, D., and N. Thomasset. 1986. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 94:57.
37. Mosmann, T. R. 1994. Properties and functions of interleukin-10. Adv. Immunol. 56:1.
38. van der Lubbe, P. A., B. A. C. Dijkmans, H. M. Markusse, U. Nassander, and F. C. Breedfeld. 1994. Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis: a placebo-controlled trial. Arthritis Rheum. 37(Suppl.):S294 (Abstr.).